Education
About Us
Working with TipRanks
Follow Us
Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
RESEARCH TOOLSreports
Total Valuation
Bioline RX Ltd Sponsored ADR has a market cap or net worth of $21.31M. The enterprise value is $13.18B.
Market Cap$21.31M
Enterprise Value$13.18B
Share Statistics
Bioline RX Ltd Sponsored ADR has 4,262,685 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,262,685
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioline RX Ltd Sponsored ADR’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -71.60%.
Return on Equity (ROE)-0.69
Return on Assets (ROA)-0.24
Return on Invested Capital (ROIC)-71.60%
Return on Capital Employed (ROCE)-0.87
Revenue Per Employee1.03M
Profits Per Employee-329.32K
Employee Count28
Asset Turnover0.74
Inventory Turnover2.95
Valuation Ratios
The current PE Ratio of Bioline RX Ltd Sponsored ADR is -74.15. Bioline RX Ltd Sponsored ADR’s PEG ratio is -66.23.
PE Ratio-74.15
PS Ratio0.00
PB Ratio394.75
Price to Fair Value50.79
Price to FCF-579.47
Price to Operating Cash Flow-581.34
PEG Ratio-66.23
Income Statement
In the last 12 months, Bioline RX Ltd Sponsored ADR had revenue of 28.94M and earned -9.22M in profits. Earnings per share was -0.12.
Revenue28.94M
Gross Profit19.68M
Operating Income-20.41M
Pretax Income-9.22M
Net Income-9.22M
EBITDA3.92M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -43.87M and capital expenditures -53.00K, giving a free cash flow of -43.93M billion.
Operating Cash Flow-43.87M
Free Cash Flow-43.93M
Free Cash Flow per Share-10.31
Dividends & Yields
Bioline RX Ltd Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.66
52-Week Price Change-81.68%
50-Day Moving Average3.58
200-Day Moving Average9.89
Relative Strength Index (RSI)53.92
Average Volume (3m)1.37M
Important Dates
Bioline RX Ltd Sponsored ADR upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateMay 27, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
Bioline RX Ltd Sponsored ADR as a current ratio of 1.76, with Debt / Equity ratio of 31.32%
Current Ratio1.76
Quick Ratio1.56
Debt to Market Cap0.02
Net Debt to EBITDA1.18
Interest Coverage Ratio-2.25
Taxes
In the past 12 months, Bioline RX Ltd Sponsored ADR has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bioline RX Ltd Sponsored ADR EV to EBITDA ratio is 2.62K, with an EV/FCF ratio of -233.58.
EV to Sales354.54
EV to EBITDA2.62K
EV to Free Cash Flow-233.58
EV to Operating Cash Flow-233.87
Balance Sheet
Bioline RX Ltd Sponsored ADR has $19.56M in cash and marketable securities with $15.04M in debt, giving a net cash position of -$4.52M billion.
Cash & Marketable Securities$19.56M
Total Debt$15.04M
Net Cash-$4.52M
Net Cash Per Share-$1.06
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of -70.52%, and net profit margin of -31.86%.
Gross Margin0.00%
Operating Margin-70.52%
Pretax Margin-31.86%
Net Profit Margin-31.86%
EBITDA Margin13.54%
EBIT Margin-0.51%
Analyst Forecast
The average price target for Bioline RX Ltd Sponsored ADR is $19.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$19.00
Price Target Upside305.12% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast91.68%
EPS Growth Forecast90.86%